Emyria to begin cannabis trial

20/01/2022 - 15:42

Bookmark

Upgrade your subscription to use this feature.

Andrew Forrest-backed Emyria is slated to start human clinical trials within weeks for a cannabinoid drug to treat psychological distress.

Subscribe to read this article.

Register or login now and receive unlimited access to our award-winning, unbiased and trusted
journalism. Your key to local business, news, insights and data.

Subscribe today for award-winning, unbiased and trusted journalism

Subscription Options